Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27919563)
Watch
English
RET M918T
genetic variant
MET918THR
M918T
RS74799832
In more languages
edit
Statements
instance of
missense mutation
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
chromosome
human chromosome 10
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
genomic start
43617416
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
genomic end
43617416
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
biological variant of
RET
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
positive therapeutic predictor for
sorafenib
medical condition treated
Tuberculosis (possibly)
determination method
CIViC evidence level B
rating
CIViC 3-star trust rating
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/1365
stated in
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer
cabozantinib
determination method
CIViC evidence level B
rating
CIViC 4-star trust rating
medical condition treated
Tuberculosis (possibly)
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7710
stated in
Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer
negative therapeutic predictor for
motesanib
determination method
CIViC evidence level D
rating
CIViC 3-star trust rating
medical condition treated
Tuberculosis (possibly)
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/76
stated in
Anti-tumor activity of motesanib in a medullary thyroid cancer model
positive diagnostic predictor for
Tuberculosis (possibly)
determination method
CIViC evidence level B
rating
CIViC 5-star trust rating
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/74
stated in
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
negative prognostic predictor for
Tuberculosis (possibly)
determination method
CIViC evidence level B
rating
CIViC 4-star trust rating
1 reference
curator
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/78
stated in
Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan.
Identifiers
CIViC variant ID
113
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
dbSNP Reference SNP number
rs74799832
1 reference
stated in
CIViC database
HGVS nomenclature
NM_020975.4:c.2753T>C
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
NP_065681.1:p.Met918Thr
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
ENST00000355710.3:c.2753T>C
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
NC_000010.10:g.43617416T>C
1 reference
stated in
CIViC database
retrieved
22 January 2022
reference URL
https://civic.genome.wustl.edu/links/variants/113
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
